Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2018.04.25
独立董事2017年度述职报告
2018.04.25
独立董事关于第四届董事会第十二次相关事项之事前认可意见
2018.04.25
独立董事关于第四届董事会第十二次会议相关事项的独立意见
2018.02.12
独立董事关于第四届董事会第十一次会议相关事项的独立意见
2018.02.12
独立董事关于第四届董事会第十一次会议相关事项的事前认可意见
2018.02.12
独立董事关于评估机构独立性、、评估假设前提合理性、、、评估方法与评估目的的相关性及评估定价公允性的独立意见
2018.01.17
独立董事关于第四届董事会第十次会议相关事项的独立意见
2018.01.06
独立董事关于第四届董事会第九次会议相关事项的独立意见
2017.10.14
独立董事关于第四届董事会第七次会议相关事项的独立意见
2017.09.12
独立董事关于本次发行股份购买资产暨关联交易的事前认可意见
第一页
上一页
9
10
11
12
13
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
